Peter Q. Eichacker

Also affiliated with National Heart Lung and Blood Institute

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Clinical Features of Patients Hospitalized for All Routes of Anthrax, 1880–2018: A Systematic Review”.

Clinical Features of Patients Hospitalized for All Routes of Anthrax, 1880–2018: A Systematic Review

Clinical Infectious Diseases(2022)10.1093/cid/ciac534

N/A

0.557DataRank · unranked

40 citations

Marissa K. Person, John S. Bradley, Thitipong Mongkolrattanothai, Nathaniel Hupert, Peter Q. Eichacker +3 more

Inhibitory Immune Checkpoint Molecule Expression in Clinical Sepsis Studies: A Systematic Review

Critical Care Medicine(2020)10.1097/ccm.0000000000004496

N/A

0.547DataRank · unranked

13 citations

Junfeng Sun, Peter Q. Eichacker, Parizad Torabi‐Parizi, Lindsay M. Busch

Comparative effectiveness research in critically ill patients: risks associated with mischaracterising usual care

Critical Care and Resuscitation(2020)10.51893/2020.2.r1

N/A

0.385DataRank · unranked

12 citations

Jeffrey Wang, Harvey G. Klein, Robert L. Danner, Peter Q. Eichacker, Charles Natanson +1 more

Checkpoint inhibitor therapy in preclinical sepsis models: a systematic review and meta-analysis

Intensive Care Medicine Experimental(2020)10.1186/s40635-019-0290-x

N/A

0DataRank · unranked

36 citations

Junfeng Sun, Xizhong Cui, Peter Q. Eichacker, Parizad Torabi‐Parizi, Lindsay M. Busch

Hydrocortisone decreases lethality and inflammatory cytokine and nitric oxide production in rats challenged with B. anthracis cell wall peptidoglycan

Intensive Care Medicine Experimental(2020)10.1186/s40635-020-00358-4

N/A

0DataRank · unranked

2 citations

Xizhong Cui, Joseph Shiloach, Jeffrey Wang, Dante A. Suffredini, Wanying Xu +5 more

A Review of the Efficacy of FDA-Approved B. anthracis Anti-Toxin Agents When Combined with Antibiotic or Hemodynamic Support in Infection- or Toxin-Challenged Preclinical Models

Toxins(2021)10.3390/toxins13010053

N/A

0DataRank · unranked

7 citations

Xizhong Cui, Yan Li, Mahtab Moayeri, Stephen H. Leppla, Peter Q. Eichacker +1 more

Comprehensive adjusted outcome data are needed to assess the impact of immune checkpoint inhibitors in cancer patients with COVID‐19: Results of a systematic review and meta‐analysis

Reviews in Medical Virology(2022)10.1002/rmv.2352

N/A

0DataRank · unranked

10 citations

Junfeng Sun, Yan Li, Xizhong Cui, Diane Cooper, Peter Q. Eichacker +2 more

Modeling current practices in critical care comparative effectiveness research

Critical Care and Resuscitation(2022)10.51893/2022.2.oa5

N/A

0DataRank · unranked

3 citations

Jeffrey Wang, Irene Cortés‐Puch, Harvey G. Klein, Peter Q. Eichacker, Diane Cooper +3 more

Effect of low-to-moderate hyperoxia on lung injury in preclinical animal models: a systematic review and meta-analysis

Intensive Care Medicine Experimental(2023)10.1186/s40635-023-00501-x

N/A

0DataRank · unranked

11 citations

Rhea Dhamapurkar, Xizhong Cui, Yan Li, Junfeng Sun, Diane Cooper +3 more

Controls, comparator arms, and designs for critical care comparative effectiveness research: It’s complicated

Clinical Trials(2023)10.1177/17407745231195094

N/A

0DataRank · unranked

8 citations

Harvey G. Klein, Robert L. Danner, Willard N. Applefeld, Jeffrey Wang, Irene Cortés‐Puch +3 more

Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry

International Journal of Infectious Diseases(2023)10.1016/j.ijid.2023.11.021

N/A

0DataRank · unranked

3 citations

Samuel Minkove, Isabel Ruíz-Camps, Simeón Eremiev, Gino M Dettorre, María Laura Fox +39 more

Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model

Frontiers in Immunology(2024)10.3389/fimmu.2023.1308358

N/A

0DataRank · unranked

3 citations

Xizhong Cui, Yan Li, Mark Jeakle, Junfeng Sun, Cumhur Y. Demirkale +9 more

Meta-analysis of niacin and NAD metabolite treatment in infectious disease animal studies suggests benefit but requires confirmation in clinically relevant models

Scientific Reports(2025)10.1038/s41598-025-95735-y

N/A

0DataRank · unranked

3 citations

Xizhong Cui, Yan Li, T. Gamble, Junfeng Sun, Samuel Minkove +4 more

Individualized Care Is Superior to Standardized Care for the Majority of Critically Ill Patients

Critical Care Medicine(2020)10.1097/ccm.0000000000004373

N/A

0DataRank · unranked

17 citations

Willard N. Applefeld, Jeffrey Wang, Robert L. Danner, Peter Q. Eichacker, Charles Natanson +1 more

A systematic review of adult animal models investigating ECMO use for ARDS: where to from here

Intensive Care Medicine Experimental(2025)10.1186/s40635-025-00781-5

N/A

0DataRank · unranked

1 citations

Xizhong Cui, Mark Jeakle, Yan Li, Nancy Terry, T. Gamble +5 more

The Effects of Obesity on Outcome in Preclinical Animal Models of Infection and Sepsis: A Systematic Review and Meta-Analysis

Journal of Obesity(2020)10.1155/2020/1508764

N/A

0DataRank · unranked

15 citations

Dominique J. Pepper, Junfeng Sun, Judith A. Welsh, Xizhong Cui, Peter Q. Eichacker +1 more

Driving blind: instituting SEP-1 without high quality outcomes data

Journal of Thoracic Disease(2020)10.21037/jtd.2019.12.100

N/A

0DataRank · unranked

37 citations

Jeffrey R. Strich, Willard N. Applefeld, Junfeng Sun, Xizhong Cui, Charles Natanson +2 more